Testosterone enanthate, sold under the brand names Delatestryl and Xyosted among others, is an androgen and anabolic steroid (AAS) prescription which is utilized predominantly in the treatment of low testosterone levels in men. It is likewise utilized in chemical treatment for transsexual men. It is given by infusion into muscle or subcutaneously typically once every one to four weeks.
Results of testosterone enanthate incorporate side effects of masculinization like skin break out, expanded hair development, voice changes, and expanded sexual desire. The medication is a manufactured androgen and anabolic steroid and subsequently is an agonist of the androgen receptor (AR), the organic objective of androgens like testosterone and dihydrotestosterone (DHT). It makes solid androgenic impacts and moderate anabolic impacts, which make it valuable for creating masculinization and reasonable for androgen substitution therapy. Testosterone enanthate is a testosterone ester and an enduring prodrug of testosterone in the body. Along these lines, it is viewed as a characteristic and bioidentical type of testosterone.
Testosterone enanthate was presented for clinical use in 1954. Alongside testosterone cypionate, testosterone undecanoate, and testosterone propionate, it is one of the most broadly utilized testosterone esters. notwithstanding its clinical use, testosterone enanthate is utilized to further develop constitution and performance. The medication is a controlled substance in numerous nations thus non-clinical use is by and large unlawful.